Elephas
Clinical trials sponsored by Elephas, explained in plain language.
-
AI vs. cancer: new test aims to predict which drugs will work
Diagnosis Recruiting nowThis study aims to develop and test a new diagnostic tool that uses artificial intelligence (AI) to analyze small pieces of a patient's tumor. The goal is to predict whether a patient will respond to certain immunotherapy cancer drugs before they start treatment. Researchers will…
Sponsor: Elephas • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC
-
AI test aims to predict best cancer drugs from tiny tumor sample
Diagnosis Recruiting nowThis study is testing a new diagnostic tool called the Cybrid platform. It aims to see if analyzing small pieces of a patient's lung tumor in a lab can accurately predict whether that patient will respond to certain immunotherapy drugs. The study will enroll 200 people with advan…
Sponsor: Elephas • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC
-
Lab tests aim to predict which cancer patients will benefit from immunotherapy
Knowledge-focused Recruiting nowThis study collects tumor tissue samples from cancer patients to research whether laboratory tests can predict which patients will respond to immunotherapy drugs. Researchers will analyze how live tumor samples react to immunotherapy treatments in the lab, then compare those resu…
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC